This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Christain Thomsen: Innovator in Opioid Receptor Research
Introduction
Christain Thomsen is a notable inventor based in Stroby, Denmark. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that interact with opioid receptors. His work is crucial for advancing treatments for various medical conditions.
Latest Patents
Thomsen holds a patent for a compound titled "1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes." This invention relates to the use of small organic compounds acting as opioid receptor ligands for the treatment of vasomotor disturbances. The patent highlights the potential of triaza-spiro compounds in addressing critical health issues.
Career Highlights
Throughout his career, Christain Thomsen has focused on innovative research that bridges the gap between chemistry and pharmacology. His dedication to understanding opioid receptors has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Thomsen has collaborated with esteemed colleagues, including Rolf Hohlweg and Brett Watson. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.
Conclusion
In summary, Christain Thomsen's work in opioid receptor research exemplifies the impact of innovative thinking in medicine. His contributions continue to pave the way for advancements in treatment options for patients.